VIMIAN GROUP AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.4 SEK | +2.26% |
|
-3.29% | -0.68% |
| 03-28 | Nordic Shares Decreased Thursday; BioGaia Series B Posted Biggest Loss | DJ |
| 03-19 | Nordic Stocks Decreased Tuesday; Autostore Holdings Posted Biggest Loss | DJ |
| Sales 2024 * | 371M 397M 4.34B 31.81B | Sales 2025 * | 419M 448M 4.9B 35.91B | Capitalization | 1.31B 1.4B 15.35B 112B |
|---|---|---|---|---|---|
| Net income 2024 * | 37M 39.56M 433M 3.17B | Net income 2025 * | 63M 67.36M 737M 5.39B | EV / Sales 2024 * | 4.22 x |
| Net Debt 2024 * | 254M 272M 2.97B 21.75B | Net Debt 2025 * | 130M 139M 1.52B 11.16B | EV / Sales 2025 * | 3.44 x |
| P/E ratio 2024 * |
32.6
x | P/E ratio 2025 * |
20
x | Employees | 1,100 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 40.37% |
More Fundamentals
* Assessed data
More news
Latest transcript on Vimian Group AB
More press releases
More news
| 1 day | +2.26% | ||
| 1 week | -3.29% | ||
| Current month | -9.54% | ||
| 1 month | -2.00% | ||
| 3 months | +3.16% | ||
| 6 months | +24.05% | ||
| Current year | -0.68% |
1 week
28.55
32.40
1 month
28.5535.40
Current year
25.1435.40
1 year
20.0837.96
3 years
20.08123.40
5 years
20.08123.40
10 years
20.08123.40
| Managers | Title | Age | Since |
|---|---|---|---|
Patrik Eriksson
CEO | Chief Executive Officer | 56 | 12-31 |
| Director of Finance/CFO | 45 | 31/12/21 | |
| Investor Relations Contact | 43 | 31/08/21 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mikael Dolsten
BRD | Director/Board Member | 65 | 31/12/20 |
Petra Rumpf
BRD | Director/Board Member | 57 | 31/12/21 |
| Director/Board Member | 54 | 31/12/22 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 773 M€ | -.--% | - | |
| 0.00% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 29.4 | +2.26% | 220,828 |
| 25/04/24 | 28.75 | -5.27% | 388,393 |
| 24/04/24 | 30.35 | +0.17% | 160,563 |
| 23/04/24 | 30.3 | -2.88% | 388,612 |
| 22/04/24 | 31.2 | +2.63% | 249,714 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 04:29 pm
More quotes
Vimian Group AB is a Sweden-based veterinary company. The Company is a parent company of the group of companies operating with a purpose of improving animal health through science and technology. The Group delivers solutions to veterinary professionals, labs and pet parents around the world. The purpose of Vimian Group is to unite companies in selected niches of animal health and help them grow faster. The Company invests in innovation and new technologies to advance veterinary medicine. The Group covers four essential and rapidly evolving areas within animal health: Specialty Pharma, Diagnostics, Veterinary Services and MedTech. Vimian provides individual businesses with access to its networks, advisory services, infrastructure and capital.
Sector
Pharmaceuticals
Calendar
02/05/2024
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
2.512
EUR
Average target price
3.355
EUR
Spread / Average Target
+33.56%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -0.68% | 1.4B | |
| -19.73% | 72.39B | |
| -11.01% | 6.54B | |
| +15.88% | 3.43B | |
| -17.27% | 1.34B | |
| -2.73% | 1.26B | |
| -28.16% | 1.2B | |
| -14.67% | 1.12B | |
| -5.37% | 990M | |
| -24.06% | 805M |
- Stock Market
- Equities
- VIMIAN Stock
